Academic Journal

Does basiliximab induction trigger lifethreatening ARDS and shock in young patients after kidney transplantation?

التفاصيل البيبلوغرافية
العنوان: Does basiliximab induction trigger lifethreatening ARDS and shock in young patients after kidney transplantation?
المؤلفون: Massart, Annick, Heenen, Sarah, Bejjani, Gilbert, Hoang, Anh Dung, Mikhalski, Dimitri, Broeders, Emine Nilufer, Creteur, Jacques, De Backer, Daniel, Abramowicz, Daniel
المصدر: Clinical nephrology
سنة النشر: 2013
المجموعة: DI-fusion : dépôt institutionnel de l'Université libre de Bruxelles (ULB)
مصطلحات موضوعية: Néphrologie - urologie, Acute respiratory distress syndrome (ARDS), Basiliximab, Induction, Renal transplantation, Shock
الوصف: Background. Kidney disease Improving Global Outcomes (KDIGO) guidelines strongly recommend administering an anti-IL-2R mAb (i.e. basiliximab) for induction in all kidney transplant recipients. We describe a life-threatening episode of shock following basiliximab injection and review the literature. Methods and Results: A 20-year-old male was given tacrolimus, methylprednisolone, mycophenolate, and basiliximab, 20 mg in the context of living-related kidney transplantation. On post-operative Day 1 (POD 1), he developed acute respiratory distress syndrome (ARDS), shock, multiple organ failure, and had a cardiac arrest. After effective resuscitation, he received rescue therapies (NO inhalation, extra-corporeal membrane oxygenation, and CVVHD) but lost the graft as the result of cortical necrosis. We conducted PubMed searches that yielded 7 similar cases; 6 required invasive ventilation. Three patients developed cardiac arrest, 3 required major inotropic support, and 2 developed MOF and myocardial depression. All but 1 patient recovered rapidly within a few days. There was no evidence for infectious, allergic, or over-hydration concerns. Although the direct causal role of basiliximab cannot be formally proven, the fact that ARDS at the time of induction therapy with other immunosuppressive agents is otherwise extremely rare suggests a direct role for basiliximab. Conclusions: Basiliximab could be associated with shock and ARDS. ; JOURNAL ARTICLE ; SCOPUS: re.j ; info:eu-repo/semantics/published
نوع الوثيقة: article in journal/newspaper
وصف الملف: No full-text files
اللغة: unknown
Relation: uri/info:doi/10.5414/CN107889; uri/info:pii/10968; uri/info:pmid/24131675; uri/info:scp/84921668296; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156159
الاتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156159
رقم الانضمام: edsbas.B8172FE5
قاعدة البيانات: BASE